![Ricardo Arjona Antolin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ricardo Arjona Antolin
Vorsitzender bei VLP The Vaccines Co. SL
Profil
Ricardo Arjona Antolin currently works at Biotechnology Development for Industry in Pharmaceuticals SLU, as Chairman from 2017 and VLP The Vaccines Co. SL, as Chairman.
Aktive Positionen von Ricardo Arjona Antolin
Unternehmen | Position | Beginn |
---|---|---|
VLP The Vaccines Co. SL
![]() VLP The Vaccines Co. SL BiotechnologyHealth Technology VLP The Vaccines Co. SL is a biotechnological company. The firm engages in the research and development of immunotherapuetic solution for people with cancer and infectious diseases. It offers a patented and proprietary antigen-display nanoplatform based on virus-like particles under the following brands: PRRSVax and CerVivax. The company was founded in 2011 and is headquartered in Valladolid, Spain. | Vorsitzender | - |
Biotechnology Development for Industry in Pharmaceuticals SLU
![]() Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Vorsitzender | 13.09.2017 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
VLP The Vaccines Co. SL
![]() VLP The Vaccines Co. SL BiotechnologyHealth Technology VLP The Vaccines Co. SL is a biotechnological company. The firm engages in the research and development of immunotherapuetic solution for people with cancer and infectious diseases. It offers a patented and proprietary antigen-display nanoplatform based on virus-like particles under the following brands: PRRSVax and CerVivax. The company was founded in 2011 and is headquartered in Valladolid, Spain. | Health Technology |
Biotechnology Development for Industry in Pharmaceuticals SLU
![]() Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Commercial Services |